These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 30748057)

  • 1. Haemophilia in Côte d'Ivoire (the Ivory Coast) in 2017: Extensive data collection as part of the World Federation of Hemophilia's twinning programme.
    Lambert C; Meité N; Sanogo I; Lobet S; Adjambri E; Eeckhoudt S; Hermans C
    Haemophilia; 2019 Mar; 25(2):236-243. PubMed ID: 30748057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophilia carrier's awareness, diagnosis, and management in emerging countries: a cross-sectional study in Côte d'Ivoire (Ivory Coast).
    Lambert C; Meité ND; Sanogo I; Lobet S; Adjambri E; Eeckhoudt S; Hermans C
    Orphanet J Rare Dis; 2019 Feb; 14(1):26. PubMed ID: 30709356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor epidemiology and genetic-related risk factors in people with haemophilia from Côte d'Ivoire.
    Lambert C; Lannoy N; Meité N; Sanogo I; Eeckhoudt S; Hermans C
    Haemophilia; 2020 Jan; 26(1):79-85. PubMed ID: 31829478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and outcomes of low-dose and low-frequency prophylaxis with recombinant extended half-life products (Fc-rFVIII and Fc-rFIX) in Ivorian children with hemophilia: Two-year experience in the setting of World Federation of Haemophilia humanitarian aid programme.
    Lambert C; Meité N; Sanogo I; Lobet S; Hermans C
    Haemophilia; 2021 Jan; 27(1):33-40. PubMed ID: 33245818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-cultural adaptation and validation of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) in Côte d'Ivoire (the Ivory Coast).
    Lambert C; Meité ND; Sanogo I; Lobet S; Hermans C; Henrard S; Blanchette V; Young NL
    Health Qual Life Outcomes; 2020 Mar; 18(1):76. PubMed ID: 32188477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of bleeding in a large prospective cohort of haemophilia A patients: A three-year follow-up of the AHEAD (Advate in HaEmophilia A outcome Database) study.
    Khair K; Mazzucconi MG; Parra R; Santagostino E; Tsakiris DA; Hermans C; Oldenburg J; Spotts G; Steinitz-Trost K; Gringeri A
    Haemophilia; 2018 Jan; 24(1):85-96. PubMed ID: 29044825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation and assessment of a self- and community-based rehabilitation programme in patients with haemophilia from Côte d'Ivoire.
    Lobet S; Meité N; Koninckx MI; Van Overstraeten A; Kamagate AM; Hermans C; Lambert C
    Haemophilia; 2019 Sep; 25(5):859-866. PubMed ID: 31393670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The WFH Haemophilia Centre Twinning Programme: 10 years of growth, 1993-2003.
    Giangrande PL; Mariani G; Black C
    Haemophilia; 2003 May; 9(3):240-4. PubMed ID: 12694512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of haemophilia on the social status and the health-related quality of life in adult Lebanese persons with haemophilia.
    Naous E; de Moerloose P; Sleilaty G; Casini A; Djambas Khayat C
    Haemophilia; 2019 Mar; 25(2):264-269. PubMed ID: 30748059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose tertiary prophylactic therapy reduces total number of bleeds and improves the ability to perform activities of daily living in adults with severe haemophilia A: a single-centre experience from Beijing.
    Hua B; Lian X; Li K; Lee A; Poon MC; Zhao Y
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):136-40. PubMed ID: 26258677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre.
    De Podestá Haje D; Ono F; De Oliveira GB; Almeida J; De Paula JC; Batista Neto LV; Silva Barros SB
    Haemophilia; 2011 Mar; 17(2):228-32. PubMed ID: 21070500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-cultural adaptation and validation of Haem-A-QoL in Côte d'Ivoire.
    Lambert C; Meité N; Sanogo I; Lobet S; von Mackensen S; Hermans C
    Haemophilia; 2020 May; 26(3):459-466. PubMed ID: 32394627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B.
    Wang C; Young G
    Haemophilia; 2018 May; 24(3):414-419. PubMed ID: 29405496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of joint damage in hemophilic children with early prophylaxis].
    Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
    Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of appropriate, culturally adapted educational tools for Ivoirian patients with haemophilia, haemophilia carriers and their families.
    Lambert C; Meité N; Sanogo I; Lobet S; Hermans C
    Haemophilia; 2019 Sep; 25(5):838-844. PubMed ID: 31359559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy: The Malmö experience.
    Osooli M; Steen Carlsson K; Astermark J; Berntorp E
    Haemophilia; 2017 Sep; 23(5):e403-e408. PubMed ID: 28758324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania.
    Saulyte Trakymiene S; Ingerslev J; Rageliene L
    Haemophilia; 2010 May; 16(3):479-86. PubMed ID: 20070384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing bleeds by treatment: new era for haemophilia changing the paradigm.
    Marijke van den Berg H
    Haemophilia; 2016 Jul; 22 Suppl 5():9-13. PubMed ID: 27405669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study.
    Scott MJ; Xiang H; Hart DP; Palmer B; Collins PW; Stephensen D; Sima CS; Hay CRM
    Haemophilia; 2019 Mar; 25(2):205-212. PubMed ID: 30408835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring joint health in haemophilia: Factors associated with deterioration.
    Kuijlaars IAR; Timmer MA; de Kleijn P; Pisters MF; Fischer K
    Haemophilia; 2017 Nov; 23(6):934-940. PubMed ID: 28873289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.